{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:19:38Z","timestamp":1791407978906,"version":"4.3.3"},"reference-count":85,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.2967\/jnumed.114.141416","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T05:41:17Z","timestamp":1416548477000},"page":"2003-2011","source":"Crossref","is-referenced-by-count":70,"title":["Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias"],"prefix":"10.2967","volume":"55","author":[{"given":"Ilya M.","family":"Nasrallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"2021051712065979000_55.12.2003.1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12239"},{"key":"2021051712065979000_55.12.2003.2","unstructured":"World Alzheimer report 2011: the benefits of early diagnosis and intervention. http:\/\/www.alz.co.uk\/research\/world-report-2011. Accessed November 4, 2014."},{"key":"2021051712065979000_55.12.2003.3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21426"},{"key":"2021051712065979000_55.12.2003.4","doi-asserted-by":"crossref","unstructured":"Herholz K. Perfusion SPECT and FDG-PET. Int Psychogeriatrics. 2011;23(suppl 2):S25\u2013S31.","DOI":"10.1017\/S1041610211000937"},{"key":"2021051712065979000_55.12.2003.5","doi-asserted-by":"crossref","unstructured":"Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias. J Nucl Med. 2008;49:390\u2013398.","DOI":"10.2967\/jnumed.107.045385"},{"key":"2021051712065979000_55.12.2003.6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-9-41"},{"key":"2021051712065979000_55.12.2003.7","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.2989"},{"key":"2021051712065979000_55.12.2003.8","doi-asserted-by":"crossref","unstructured":"Landau SM, Breault C, Joshi AD, et al. Amyloid-beta imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013;54:70\u201377.","DOI":"10.2967\/jnumed.112.109009"},{"key":"2021051712065979000_55.12.2003.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70142-4"},{"key":"2021051712065979000_55.12.2003.10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"2021051712065979000_55.12.2003.11","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2002.1208"},{"key":"2021051712065979000_55.12.2003.12","doi-asserted-by":"crossref","unstructured":"Davatzikos C, Xu F, An Y, Fan Y, Resnick SM. Longitudinal progression of Alzheimer\u2019s-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain. 2009;132:2026\u20132035.","DOI":"10.1093\/brain\/awp091"},{"key":"2021051712065979000_55.12.2003.13","doi-asserted-by":"crossref","unstructured":"Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain. 2007;130:2616\u20132635.","DOI":"10.1093\/brain\/awm177"},{"key":"2021051712065979000_55.12.2003.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823b9c5e"},{"key":"2021051712065979000_55.12.2003.15","doi-asserted-by":"crossref","unstructured":"Fjell AM, Walhovd KB, Fennema-Notestine C, et al. One-year brain atrophy evident in healthy aging. J Neurosci. 2009;29:15223\u201315231.","DOI":"10.1523\/JNEUROSCI.3252-09.2009"},{"key":"2021051712065979000_55.12.2003.16","doi-asserted-by":"crossref","unstructured":"Nosheny RL Insel PS Truran D . Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. August 1, 2014 [Epub ahead of print].","DOI":"10.1016\/j.neurobiolaging.2014.07.036"},{"key":"2021051712065979000_55.12.2003.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.04.007"},{"key":"2021051712065979000_55.12.2003.18","first-page":"54","article-title":"Preclinical Alzheimer disease: the challenges ahead. Nat Rev","volume":"9","author":"Sperling","year":"2013","journal-title":"Neurol."},{"key":"2021051712065979000_55.12.2003.19","doi-asserted-by":"crossref","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u2013269.","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2021051712065979000_55.12.2003.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"2021051712065979000_55.12.2003.21","doi-asserted-by":"crossref","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u2013292.","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2021051712065979000_55.12.2003.22","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.20573"},{"key":"2021051712065979000_55.12.2003.23","doi-asserted-by":"crossref","unstructured":"Yushkevich PA Pluta JB Wang H . Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp. September 2, 2014 [Epub ahead of print].","DOI":"10.1002\/hbm.22627"},{"key":"2021051712065979000_55.12.2003.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.11.010"},{"key":"2021051712065979000_55.12.2003.25","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420114"},{"key":"2021051712065979000_55.12.2003.26","doi-asserted-by":"crossref","unstructured":"Kadir A, Almkvist O, Forsberg A, et al. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:198 e1\u2013e14.","DOI":"10.1016\/j.neurobiolaging.2010.06.015"},{"key":"2021051712065979000_55.12.2003.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.07.005"},{"key":"2021051712065979000_55.12.2003.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"2021051712065979000_55.12.2003.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1194-1"},{"key":"2021051712065979000_55.12.2003.30","doi-asserted-by":"crossref","unstructured":"Teune LK, Bartels AL, de Jong BM, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord. 2010;25:2395\u20132404.","DOI":"10.1002\/mds.23291"},{"key":"2021051712065979000_55.12.2003.31","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269790.05105.16"},{"key":"2021051712065979000_55.12.2003.32","doi-asserted-by":"publisher","DOI":"10.1177\/1533317510363468"},{"key":"2021051712065979000_55.12.2003.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.03.014"},{"key":"2021051712065979000_55.12.2003.34","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21598"},{"key":"2021051712065979000_55.12.2003.35","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Wiste HJ, Vemuri P, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain. 2010;133:3336\u20133348.","DOI":"10.1093\/brain\/awq277"},{"key":"2021051712065979000_55.12.2003.36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","article-title":"Early-versus late-onset Alzheimer\u2019s disease: more than age alone","volume":"19","author":"Koedam","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"2021051712065979000_55.12.2003.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0412-x"},{"key":"2021051712065979000_55.12.2003.38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c0d427"},{"key":"2021051712065979000_55.12.2003.39","doi-asserted-by":"crossref","unstructured":"Wolk DA, Price JC, Madeira C, et al. Amyloid imaging in dementias with atypical presentation. Alzheimers Dement. 2012;8:389\u2013398.","DOI":"10.1016\/j.jalz.2011.07.003"},{"key":"2021051712065979000_55.12.2003.40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a55fa2"},{"key":"2021051712065979000_55.12.2003.41","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1545"},{"key":"2021051712065979000_55.12.2003.42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318202038c"},{"key":"2021051712065979000_55.12.2003.43","unstructured":"Jeong Y, Cho SS, Park JM, et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med. 2005;46:233\u2013239."},{"key":"2021051712065979000_55.12.2003.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2005.10.008"},{"key":"2021051712065979000_55.12.2003.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-010-0184-0"},{"key":"2021051712065979000_55.12.2003.46","doi-asserted-by":"crossref","unstructured":"Villemagne VL, Ong K, Mulligan RS, et al. Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210\u20131217.","DOI":"10.2967\/jnumed.111.089730"},{"key":"2021051712065979000_55.12.2003.47","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259035.98480.ed"},{"key":"2021051712065979000_55.12.2003.48","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.216.1.r00ma0531"},{"key":"2021051712065979000_55.12.2003.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(08)70027-0"},{"key":"2021051712065979000_55.12.2003.50","doi-asserted-by":"crossref","unstructured":"McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417\u2013423.","DOI":"10.3233\/JAD-2006-9S347"},{"key":"2021051712065979000_55.12.2003.51","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.127878"},{"key":"2021051712065979000_55.12.2003.52","doi-asserted-by":"crossref","unstructured":"Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer\u2019s disease. Brain. 2007;130:708\u2013719.","DOI":"10.1093\/brain\/awl388"},{"key":"2021051712065979000_55.12.2003.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.06.017"},{"key":"2021051712065979000_55.12.2003.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.09.015"},{"key":"2021051712065979000_55.12.2003.55","doi-asserted-by":"crossref","unstructured":"Du AT, Schuff N, Kramer JH, et al. Different regional patterns of cortical thinning in Alzheimer\u2019s disease and frontotemporal dementia. Brain. 2007;130:1159\u20131166.","DOI":"10.1093\/brain\/awm016"},{"key":"2021051712065979000_55.12.2003.56","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a4124e"},{"key":"2021051712065979000_55.12.2003.57","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1133"},{"key":"2021051712065979000_55.12.2003.58","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1983.04050110029003"},{"key":"2021051712065979000_55.12.2003.59","doi-asserted-by":"crossref","unstructured":"Tripathi M, Tripathi M, Damle N, et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET\/CT. Neuroradiol J. 2014;27:13\u201321.","DOI":"10.15274\/NRJ-2014-10002"},{"key":"2021051712065979000_55.12.2003.60","doi-asserted-by":"crossref","unstructured":"Perani D, Schillaci O, Padovani A, et al. A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. BioMed Res Int. 2014;2014:785039.","DOI":"10.1155\/2014\/246586"},{"key":"2021051712065979000_55.12.2003.61","doi-asserted-by":"publisher","DOI":"10.1159\/000358233"},{"key":"2021051712065979000_55.12.2003.62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-122233","article-title":"Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population","volume":"36","author":"Prins","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"2021051712065979000_55.12.2003.63","doi-asserted-by":"crossref","unstructured":"Prestia A, Caroli A, Herholz K, et al. Diagnostic accuracy of markers for prodromal Alzheimer\u2019s disease in independent clinical series. Alzheimers Dement. 2013;9:677\u2013686.","DOI":"10.1016\/j.jalz.2012.09.016"},{"key":"2021051712065979000_55.12.2003.64","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.7.1397"},{"key":"2021051712065979000_55.12.2003.65","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180958.22678.91"},{"key":"2021051712065979000_55.12.2003.66","doi-asserted-by":"crossref","unstructured":"Nestor SM, Rupsingh R, Borrie M, et al. Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database. Brain. 2008;131:2443\u20132454.","DOI":"10.1093\/brain\/awn146"},{"key":"2021051712065979000_55.12.2003.67","doi-asserted-by":"crossref","unstructured":"Josephs KA Jr, Whitwell JL, Weigand SD, et al. Predicting functional decline in behavioural variant frontotemporal dementia. Brain. 2011;134:432\u2013448.","DOI":"10.1093\/brain\/awq348"},{"key":"2021051712065979000_55.12.2003.68","doi-asserted-by":"crossref","unstructured":"Nedelska Z Ferman TJ Boeve BF . Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging. July 15, 2014 [Epub ahead of print].","DOI":"10.1212\/WNL.82.10_supplement.S48.004"},{"key":"2021051712065979000_55.12.2003.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.07.013"},{"key":"2021051712065979000_55.12.2003.70","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a8237e"},{"key":"2021051712065979000_55.12.2003.71","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000467"},{"key":"2021051712065979000_55.12.2003.72","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24040"},{"key":"2021051712065979000_55.12.2003.73","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182918ca6"},{"key":"2021051712065979000_55.12.2003.74","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120010"},{"key":"2021051712065979000_55.12.2003.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.09.069"},{"key":"2021051712065979000_55.12.2003.76","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-012-9180-5"},{"key":"2021051712065979000_55.12.2003.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.04.056"},{"key":"2021051712065979000_55.12.2003.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.04.025"},{"key":"2021051712065979000_55.12.2003.79","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2343040197"},{"key":"2021051712065979000_55.12.2003.80","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f11e35"},{"key":"2021051712065979000_55.12.2003.81","doi-asserted-by":"crossref","unstructured":"Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer\u2019s disease: an independent component analysis. J Neurosci. 2006;26:10222\u201310231.","DOI":"10.1523\/JNEUROSCI.2250-06.2006"},{"key":"2021051712065979000_55.12.2003.82","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.1654"},{"key":"2021051712065979000_55.12.2003.83","doi-asserted-by":"crossref","unstructured":"Fodero-Tavoletti MT, Okamura N, Furumoto S, et al. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer\u2019s disease. Brain. 2011;134:1089\u20131100.","DOI":"10.1093\/brain\/awr038"},{"key":"2021051712065979000_55.12.2003.84","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.631"},{"key":"2021051712065979000_55.12.2003.85","doi-asserted-by":"crossref","unstructured":"Kreisl WC, Lyoo CH, McGwier M, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease. Brain. 2013;136:2228\u20132238.","DOI":"10.1093\/brain\/awt145"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.114.141416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:21:27Z","timestamp":1717568487000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.114.141416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":85,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.2967\/jnumed.114.141416"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.114.141416","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]}}}